NAMPT and myeloid neoplasm: Nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in the nicotinamide adenine dinucleotide (NAD) salvage pathway, is a potential target in cancer [154] and of particular interest in myeloid neoplasms due to the location of the NAMPT gene at 7q22.3.